Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Nasdaq, Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $52.0B | |
|---|---|---|
| Revenue (ttm) | 5.8B | |
| Net income (ttm) | 2.1B | |
| EPS (ttm) | $3.66 | |
| Shares out | 555M | |
| P/E (trailing) | 28.8x | |
| P/E (forward) | 20.8x | |
| Dividend | $1.24 (1.18%) | |
| Volume | 2,073,873 | |
| Beta | 1.00 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | — | $6.23B | $6.06B | $7.40B | $8.26B | +9.9% |
| Gross profit | — | $2.34B | $2.55B | $2.99B | $3.49B | +14.3% |
| Operating income | — | $1.60B | $1.67B | $1.85B | $2.50B | +16.1% |
| Net income | — | $1.13B | $1.06B | $1.12B | $1.79B | +16.7% |
| EPS (diluted) | $2.35 | $2.26 | $2.08 | $1.93 | $3.09 | +7.1% |
| EBITDA | — | $1.85B | $2.00B | $2.46B | $3.13B | +19.1% |
| R&D | — | — | — | — | — | — |
| SG&A | — | $420.0M | $417.0M | $427.0M | $424.0M | +0.3% |
Recent company headlines from major financial publishers.
Accelerating IPO activity and strong demand for Anti-Financial Crime (Verafin) and index products drive structural growth outperformance and margin expansion.
A near-term revenue contraction driven by portfolio reshaping transitions into steady high-single-digit growth, with margins reverting to 40%.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.1% | $87.6 | $97.3 | $109 | $125 | $128 |
| 8.1% | $73.2 | $79.8 | $87.6 | $97.3 | $109 |
| 9.1% | $62.8 | $67.6 | $73.2 | $79.8 | $87.6 |
| 10.1% | $55.0 | $58.7 | $62.8 | $67.6 | $73.2 |
| 11.1% | $49.0 | $51.8 | $55.0 | $58.7 | $62.8 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
